NOVONIX Ltd Files 6-K for December 2024
Ticker: NVNXF · Form: 6-K · Filed: Dec 31, 2024 · CIK: 1859795
Sentiment: neutral
Topics: disclosure, filing, substantial-holding
TL;DR
NOVONIX Ltd filed a 6-K for Dec 2024, reporting Appendix 3H changes.
AI Summary
NOVONIX Limited filed a Form 6-K on December 30, 2024, reporting Appendix 3H, which details changes in their substantial holding. This filing is for the month of December 2024 and indicates that NOVONIX Limited is a foreign private issuer filing its annual reports under Form 20-F.
Why It Matters
This filing provides an update on significant changes in shareholdings, which can be an indicator of investor confidence or strategic shifts within the company.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of changes in substantial holdings and does not contain information about financial performance or significant operational changes.
Key Players & Entities
- NOVONIX Limited (company) — Filer of the 6-K report
- Appendix 3H (document) — Specific exhibit filed with the 6-K
- December 2024 (date) — Reporting period for the 6-K
- Form 20-F (document) — Annual report form used by the company
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer has made or is required to make public pursuant to the laws of its home country, or that it has filed or will file with a stock exchange, or that it has distributed or will distribute to its security holders.
What specific exhibit is mentioned in this 6-K filing?
The specific exhibit mentioned is Appendix 3H.
What does Appendix 3H typically relate to?
Appendix 3H typically relates to notifications of changes in substantial holding.
What is the fiscal year end for NOVONIX Limited?
The fiscal year end for NOVONIX Limited is December 31.
Under which act is this Form 6-K filed?
This Form 6-K is filed under the Securities Exchange Act of 1934.
Filing Stats: 207 words · 1 min read · ~1 pages · Grade level 12.9 · Accepted 2024-12-31 09:07:53
Filing Documents
- nvx-6k-dec-24-12-30_3hin.htm (6-K) — 19KB
- nvx-ex99_1.htm (EX-99.1) — 66KB
- nvx-ex99_2.htm (EX-99.2) — 15KB
- img58969013_0.jpg (GRAPHIC) — 1KB
- img59892534_0.jpg (GRAPHIC) — 56KB
- 0000950170-24-141338.txt ( ) — 180KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Dr. John Christopher Burns Dr. John Christopher Burns Chief Executive Officer Date: December 31, 2024